PTH and chronic kidney disease: Fukagawa et al. have demonstrated that the accumulation of IS in the blood of CKD patients induces skeletal resistance to parathyroid hormone (PTH), inhibits intracellular cAMP production, decreases PTH receptor expression, and induces oxidative stress in osteoblasts [7].